Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Clomiphene Citrate and letrozole

Phase 1Small molecule

HHITEC-Institute of Medical Sciences

Clomiphene Citrate and letrozole is one of 2 small molecule programs targeting Ovulation Induction. It is currently in Phase 1.

1

Indications

1

Total Trials

1

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ovulation InductionRecruiting

Ovulation InductionPhase 1

Recruiting

Competition

Competitive Landscape

2 competitors in Ovulation Induction

#DrugCompanyPhaseTrials

Mucinex

RReckitt Benckiser LLC

Clomiphene Citrate and letrozole

HHITEC-Institute of Medical Sciences

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ovulation Induction1 trial

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

Recruiting·HHITEC-Institute of Medical Sciences·Phase 1·NCT06813118·42 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Clomiphene Citrate and letrozole. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Clomiphene Citrate and letrozole compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Clomiphene Citrate and letrozole. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — HITEC-Institute of Medical Sciences company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: HHITEC-Institute of Medical Sciences

Related News